X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (12350) 12350
Newspaper Article (1496) 1496
Publication (1350) 1350
Newsletter (502) 502
Book Review (227) 227
Trade Publication Article (149) 149
Book Chapter (119) 119
Magazine Article (119) 119
Conference Proceeding (43) 43
Government Document (36) 36
Dissertation (23) 23
Book / eBook (17) 17
Web Resource (11) 11
Data Set (1) 1
Paper (1) 1
Reference (1) 1
Report (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
prostate cancer (9762) 9762
humans (8358) 8358
male (8204) 8204
index medicus (6396) 6396
androgens (5501) 5501
oncology (5204) 5204
cancer (3548) 3548
prostatic neoplasms - drug therapy (3294) 3294
aged (3257) 3257
urology & nephrology (3014) 3014
care and treatment (2889) 2889
prostatic neoplasms - pathology (2876) 2876
middle aged (2693) 2693
androgen antagonists - therapeutic use (2655) 2655
research (2456) 2456
metastasis (2358) 2358
androgen deprivation therapy (2329) 2329
radiotherapy (1924) 1924
prostate (1890) 1890
men (1886) 1886
radical prostatectomy (1781) 1781
health aspects (1715) 1715
cancer therapies (1714) 1714
androgen-deprivation therapy (1677) 1677
prostatic neoplasms - therapy (1506) 1506
animals (1473) 1473
treatment outcome (1461) 1461
aged, 80 and over (1457) 1457
risk factors (1413) 1413
testosterone (1411) 1411
androgen receptor (1386) 1386
prostatic neoplasms - radiotherapy (1321) 1321
carcinoma (1297) 1297
urology (1282) 1282
prostatic neoplasms - metabolism (1249) 1249
prostate-specific antigen - blood (1235) 1235
androgen deprivation (1229) 1229
chemotherapy (1134) 1134
survival (1128) 1128
therapy (1103) 1103
analysis (1098) 1098
antineoplastic agents, hormonal - therapeutic use (1084) 1084
castration (1063) 1063
patients (1011) 1011
cell line, tumor (1004) 1004
radiation-therapy (999) 999
prognosis (972) 972
prostatic neoplasms - mortality (964) 964
receptors, androgen - metabolism (939) 939
expression (937) 937
androgen antagonists - adverse effects (920) 920
endocrinology & metabolism (897) 897
prostatic neoplasms - blood (893) 893
tumors (889) 889
oncology, experimental (884) 884
quality of life (879) 879
prostatic neoplasms - genetics (876) 876
radiation therapy (876) 876
prostatic neoplasms - surgery (872) 872
article (869) 869
risk (850) 850
development and progression (845) 845
clinical trials (842) 842
prostatectomy (837) 837
progression (830) 830
quality-of-life (793) 793
disease progression (781) 781
mortality (781) 781
neoplasm staging (762) 762
radiology, nuclear medicine & medical imaging (762) 762
orchiectomy (755) 755
mice (747) 747
retrospective studies (742) 742
gene expression (734) 734
prostate-specific antigen (692) 692
medicine (689) 689
studies (665) 665
hormones (664) 664
apoptosis (663) 663
combined modality therapy (652) 652
randomized controlled-trial (650) 650
deprivation (645) 645
hematology, oncology and palliative medicine (644) 644
adult (638) 638
disease-free survival (637) 637
time factors (633) 633
follow-up studies (632) 632
metastases (630) 630
medical research (628) 628
antigens (623) 623
prostate-cancer (622) 622
suppression (616) 616
osteoporosis (615) 615
prostatic neoplasms (607) 607
receptors, androgen - genetics (603) 603
diagnosis (597) 597
patient outcomes (594) 594
urologic and male genital diseases (580) 580
genetic aspects (579) 579
cancer patients (571) 571
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (14160) 14160
French (197) 197
German (195) 195
Spanish (103) 103
Japanese (51) 51
Chinese (17) 17
Russian (10) 10
Czech (6) 6
Italian (5) 5
Korean (4) 4
Polish (4) 4
Croatian (3) 3
Dutch (3) 3
Portuguese (3) 3
Turkish (3) 3
Hungarian (2) 2
Serbian (2) 2
Afrikaans (1) 1
Arabic (1) 1
Belarusian (1) 1
Danish (1) 1
Slovak (1) 1
Slovenian (1) 1
Welsh (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 08/2009, Volume 361, Issue 8, pp. 745 - 755
Men receiving androgen-deprivation therapy for nonmetastatic prostate cancer are at high risk for bone loss and fractures. This placebo-controlled study... 
ZOLEDRONIC ACID | MEDICINE, GENERAL & INTERNAL | PLACEBO | BONE-MINERAL DENSITY | FRACTURES | RISK | COMPLICATIONS | RANDOMIZED CONTROLLED-TRIAL | POSTMENOPAUSAL WOMEN | OSTEOPOROSIS | ALENDRONATE | Lumbar Vertebrae - injuries | Humans | Middle Aged | Antibodies, Monoclonal - adverse effects | Fractures, Bone - epidemiology | Antibodies, Monoclonal - therapeutic use | Male | Osteoporosis - drug therapy | Prostatic Neoplasms - physiopathology | Bone Remodeling - drug effects | Incidence | Antibodies, Monoclonal, Humanized | Spinal Fractures - prevention & control | RANK Ligand - pharmacology | Injections, Subcutaneous | Aged, 80 and over | RANK Ligand - therapeutic use | Gonadotropin-Releasing Hormone - agonists | Lumbar Vertebrae - physiology | Prostatic Neoplasms - drug therapy | RANK Ligand - adverse effects | Osteoporosis - chemically induced | Bone Density Conservation Agents - adverse effects | Double-Blind Method | Prostatic Neoplasms - surgery | Antibodies, Monoclonal - pharmacology | Spinal Fractures - epidemiology | Bone Density Conservation Agents - therapeutic use | Lumbar Vertebrae - drug effects | Denosumab | Bone Density Conservation Agents - pharmacology | Orchiectomy | Bone Density - drug effects | Androgen Antagonists - therapeutic use | Aged | Androgen Antagonists - adverse effects | Fractures, Bone - prevention & control | Osteoporosis | Bone density | Prostate cancer | Older people | Men | Index Medicus | Abridged Index Medicus
Journal Article
Lancet, The, ISSN 0140-6736, 2011, Volume 378, Issue 9809, pp. 2104 - 2111
Journal Article